Saba Capital files Form 4 reporting ECAT share sales
Rhea-AI Filing Summary
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open‑market sales of common shares over three dates. The transactions were: 13,647 shares at $16.62 on 10/09/2025, 26,858 shares at $16.59 on 10/10/2025, and 19,408 shares at $16.58 on 10/13/2025. Following these sales, Saba reported 27,618,258 shares beneficially owned indirectly.
Positive
- None.
Negative
- None.
Insights
Insider trimmed position by a very small amount; ownership remains large and indirect. Neutral signal.
The filing reports open‑market sales of **BlackRock ESG Capital Allocation Term Trust (ECAT)** shares by a reporting person over three days: 13,647 shares at
This reduces the reported holder’s stake by about
What it means: a large holder executed modest sales across several days at prices around
FAQ
What did Saba Capital disclose for ECAT in this Form 4?
How many ECAT shares did Saba Capital sell and at what prices?
What is Saba Capital’s relationship to ECAT?
How many ECAT shares did Saba Capital report owning after the transactions?
Were the ECAT transactions direct or indirect holdings?
Were any derivative securities involved in these ECAT transactions?